25th Bio-IT World Conference & Expo 2026
日期:2026年5月19-21日
地点:美國, 馬薩諸塞州, 波士頓, Omni Boston Hotel at the Seaport
Choose your language
Chinese
Japanese
Korean
English

探索生命科学、技术和生物医学研究上创新的 3 天

11 分会 | 3 座谈会 | 2026年5月19日 – 21日

欢迎来到Bio-IT Conference & Expo

庆祝精准医疗领域创新与合作二十五年

Bio-IT World Conference & Expo是向与会者介绍可解决问题、加速科学发展并推动精准医疗未来的技术和分析方法,全球数一数二的盛会。今年将迎向第 25 届的该盛会邀集了生物制药、临床研究、医疗保健、资讯学和技术领域上超过2,900 名领导人物,来此交流想法、展示解决方案,目标是推动可突破生物医学研究、药物研发和患者疗效界限的合作。涵括全体主题演讲、专题研讨会、技术研讨会和体验式试行演示等超过200个单元的Bio-IT World,将提供一个无以伦比的机会,供您探索正在重新定义 研发和临床护理的工具、平台、策略。从人工智慧、生成式人工智慧和机器学习,到多模态和真实世界数据策略、公平人工智慧/开源实践、试点计划、新产品发布以及生物技术投资趋势,我们将推动变革性对话,将创新转化为可衡量的价值。

Bio-IT World 不仅仅是一场会议。它同时也是可塑造促进探索、加速科学发展、定义下一代精准医疗对话的社群平台。

2025 Highlights - Testimonials
Metric - 11 Tracks
Metric - 200+ Presentations
Metric - 310+ Speakers
Metric - 3,000+ Attendees
Metric - 30+ Countries
Metric - 150+ Exhibitors

2026 白金赞助商

Premier Sponsors
View All Sponsors


2025 Bio-IT World Plenary Keynotes

Abbie Celniker, PhD

Abbie Celniker, PhD
Partner, Third Rock Ventures LLC

James J. Collins, PhD

James J. Collins, PhD
Termeer Professor, Medical Engineering & Science, Massachusetts Institute of Technology

Tris Dyson

Tris Dyson
Founder, Challenge Works

Tala Fakhouri, PhD, MPH

Tala Fakhouri, PhD, MPH
Associate Director for Data Science and AI Policy, FDA

Robert C. Green, MD, MPH

Robert C. Green, MD, MPH
Professor and Director of Genomes2People Research, Mass General Brigham, Broad Institute, Ariadne Labs and Harvard Medical School

Per Greisen, PhD

Per Greisen, PhD
President, BioMap

Sofia Guerra

Sofia Guerra
Vice President, Bessemer Venture Partners

Subha Madhaven, PhD

Subha Madhavan, PhD
Vice President and Head, AI/ML, Quantitative and Digital Sciences, Pfizer Inc.

Sonya Makhni, MD

Sonya Makhni, MD
Medical Director, Mayo Clinic Platform

Jeff Rothstein, MD, PhD

Jeff D. Rothstein, MD, PhD
Professor, Neurology and Neuroscience; Director, Brain Science Institute, Johns Hopkins University

Justin M. Scheer, PhD

Justin M. Scheer, PhD
Vice President In Silico Discovery & Head, Molecular Computational Team, Johnson & Johnson Innovative Medicine

Alex Zhavoronkov, PhD

Alex Zhavoronkov, PhD
Founder & CEO, Insilico Medicine

Scenes from Bio-IT World Expo 2024 - Insights and Collaboration